Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2025-03-24 00:00:00 ET · period of report 2025-03-20 · accession 0001415889-25-008846 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-24 | 2025-03-20 | KNSA | Ragosa Mark | CFO | M - OptEx | $12.97 | +15.9K | 39.3K | +68% | +$206.8K |
| D | 2025-03-24 | 2025-03-20 | KNSA | Ragosa Mark | CFO | S - Sale+OE | $23.11 | -15.9K | 23.4K | -41% | -$368.5K |
| D | 2025-03-24 | 2025-03-20 | KNSA | Ragosa Mark | CFO | M - OptEx | $0.00 | -15.9K | 8,374 | -66% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2025-03-20 | M | A | 15,944 | $12.97 | 39,326 | D | — | — | |
| 2 | Common | Class A Ordinary Share | 2025-03-20 | S | D | 15,944 | $23.11 | 23,382 | D | — | — | (F2) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $23.10 and $23.185. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 3 | Derivative | Share Option | 2025-03-20 | M | D | 15,944 | $0.00 | 8,374 | D | $12.97 · — to 2031-09-01 | 15,944 Class A Ordinary Share | (F3) The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 2, 2021. |